Mary Kay Fenton
2014 - Achillion Pharmaceuticals
In 2014, Mary Kay Fenton earned a total compensation of $1.7M as Executive Vice President and Chief Financial Officer at Achillion Pharmaceuticals, a 74% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $158,479 |
|---|---|
| Option Awards | $1,209,436 |
| Salary | $347,679 |
| Other | $8,124 |
| Total | $1,723,718 |
Fenton received $1.2M in option awards, accounting for 70% of the total pay in 2014.
Fenton also received $158.5K in non-equity incentive plan, $347.7K in salary and $8.1K in other compensation.
Rankings
In 2014, Mary Kay Fenton's compensation ranked 5,156th out of 13,032 executives tracked by ExecPay. In other words, Fenton earned more than 60.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,156 out of 13,032 | 60th |
Division Manufacturing | 1,838 out of 4,965 | 63rd |
Major group Chemicals And Allied Products | 608 out of 1,690 | 64th |
Industry group Drugs | 463 out of 1,369 | 66th |
Industry Pharmaceutical Preparations | 370 out of 1,042 | 65th |
Source: SEC filing on April 17, 2017.
Fenton's colleagues
We found four more compensation records of executives who worked with Mary Kay Fenton at Achillion Pharmaceuticals in 2014.
2014
Milind Deshpande
Achillion Pharmaceuticals
Chief Executive Officer
2014
David Apelian
Achillion Pharmaceuticals
Chief Medical Officer
2014
Joseph Truitt
Achillion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2014
Gautam Shah
Achillion Pharmaceuticals